Min Oh

Min is an associate in Osler’s Corporate group. His practice focuses on mergers and acquisitions, corporate finance and securities, and general corporate matters. Min received his J.D. from University of Toronto, where he worked as a Research Assistant for Associate Dean, Christopher Essert. Min also was an Upper Year Executive for the Business Law Society, a Senior Editor at the Critical Analysis of Law Review and the Operations Lead for the U of T Legal Hackers team.

Prior to law school, Min obtained an M.Sc. degree in Interdisciplinary Oncology and has published numerous research papers on cancer therapeutics.

Min joined the firm as a summer student in 2021 and completed his articles with the firm in 2023.

Representative Work

  • Emera

    Emera Inc. in the sale of its interest in the Labrador Island Link

  • Kyndryl

    Kyndryl in the sale of its Securities Industry Services business to Broadridge

  • First Capital REIT

    The agents in connection with First Capital REIT’s offering of $300 million Series B unsecured debentures

  • Contractor Compliance

    Contractor Compliance in its acquisition by VelocityEHS

Latest Insights

  • Blog Jun 16, 2021

    SEC to revisit proxy advisory firm rules

    In their blog, Osler’s Andrew MacDougall and Min Oh comment on the direction that was given to U.S. Securities and Exchange Commission staff to...

    Read more

Media Mentions

  • Osler News Sep 20, 2023

    Osler welcomes the 2023 first-year associates to the Toronto office

    Osler Toronto is pleased to welcome the following first-year associates:

    Read more

Community Involvement

  • The 519, Board Member

Speaking and Writing

Published Work

  • O’Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg A, Martinez V, Lu D, Oh M, Coe B, Thu K, Somwar R, Lam S, Lam W, Unni A, Beverly L, & Lockwood W. “Integrative Genomic Analysis Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis.” (2019) Journal of Thoracic Oncology 14:4, 01 April 2019.
  • Unni A, Harbourne B, Oh M, Wild S, Ferrarone J, Lockwood W, & Varmus H. “Hyperactivation of ERK by Multiple Mechanism is Toxic to RTK-RAS Mutation-Driven Lung Adenocarcinoma Cells.” (2018) eLife 7:e33718, 26 November 2018.
  • Leung A, Chansey V, Melong N, Oh M, Chen K, Enfield K, Backstrom I, Warburton C, Yapp D, Berman J, Bally M, & Lockwood W. “In Vivo Validation of PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target.” (2017) Clinical Cancer Research 23:21, 08 August 2017.



  • University of Toronto, JD
  • University of British Columbia, MSc
  • University of British Columbia, BMLSc


  • English
  • Korean

Professional Affiliations

  • Canadian Bar Association
  • Ontario Bar Association